Clinical Trial Update: Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure [Phase 4]

View source ↗

Summary

Phase 4 trial comparing indacaterol vs tiotropium in women with COPD due to biomass exposure, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)
• Spiriva (tiotropium)

Snippet

Sponsor: National Institute of Respiratory Diseases, Mexico | Conditions: COPD | Phase 4 | Status: COMPLETED